Universal Time: 13:47  |  Local Time: 13:47 (3h GMT)
Select your timezone:

Promises of big data and AI - facts or fiction?

Monday September 23, 2024 - 15:40 to 16:40

Room: Emirgan 2

252.2 Application of AI in transplant pathology

Weijia Zhang, United States

Icahn School of Medicine at Mount Sinai


Dr. Zhang is a bioinformatician and native of China. He has been trained in both cell biology and computer science and has extensive experience in genomic analysis. His current research focuses on development and implementation of bioinformatics tools/pipeline in high throughput genomic analysis of research and clinical specimen.
He serves as the Bioinformatics Director and is the key person in genomic data analysis of Electronic Medican Records (EMR) - linked specimens in Biobank of the Institute of Personalized Medicine (IPM).
Dr. Zhang is a Co-investigator of the NHGRI-funded U01 grant ‘Biorepositories for Genomic Medicine in Diverse Communities’, and is responsible for SNP and sequencing data analysis for projects of the National Human Genome Research Institute's ‘Electronic Medical Records and Genomics’ (eMERGE) II Network at MSSM. He is also a subcontract site - Principal Investigator of several National Institutes of Health funded projects including ' The Pathogenesis of HIV-Associated Nephropathy', ' Targeting Renal Inflammatory Pathways of SLE Nephritis in Mouse and Man' and ' DIaT as a transcriptional regulator of non-replicating Mycobacterium tuberculosis'.

Presentations by Weijia Zhang

Social Media Promotion Image

right-click to download

© 2024 TTS 2024